Japan
· Delayed Price · Currency is JPY Sundrug Statistics
Total Valuation
Sundrug has a market cap or net worth of JPY 517.93 billion. The enterprise value is 491.64 billion.
| Market Cap | 517.93B |
| Enterprise Value | 491.64B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Sundrug has 116.97 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 116.97M |
| Shares Outstanding | 116.97M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 4.59% |
| Owned by Institutions (%) | 27.90% |
| Float | 67.02M |
Valuation Ratios
The trailing PE ratio is 16.84 and the forward PE ratio is 15.73. Sundrug's PEG ratio is 2.97.
| PE Ratio | 16.84 |
| Forward PE | 15.73 |
| PS Ratio | 0.65 |
| PB Ratio | 1.92 |
| P/TBV Ratio | 1.98 |
| P/FCF Ratio | 67.15 |
| P/OCF Ratio | 12.58 |
| PEG Ratio | 2.97 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.16, with an EV/FCF ratio of 63.74.
| EV / Earnings | 15.99 |
| EV / Sales | 0.61 |
| EV / EBITDA | 8.16 |
| EV / EBIT | 11.45 |
| EV / FCF | 63.74 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.69 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.63 |
| Debt / FCF | 5.01 |
| Interest Coverage | 271.32 |
Financial Efficiency
Return on equity (ROE) is 11.76% and return on invested capital (ROIC) is 9.33%.
| Return on Equity (ROE) | 11.76% |
| Return on Assets (ROA) | 6.44% |
| Return on Invested Capital (ROIC) | 9.33% |
| Return on Capital Employed (ROCE) | 14.10% |
| Revenue Per Employee | 120.36M |
| Profits Per Employee | 4.62M |
| Employee Count | 6,662 |
| Asset Turnover | 1.86 |
| Inventory Turnover | 6.29 |
Taxes
In the past 12 months, Sundrug has paid 12.82 billion in taxes.
| Income Tax | 12.82B |
| Effective Tax Rate | 29.42% |
Stock Price Statistics
The stock price has increased by +10.57% in the last 52 weeks. The beta is 0.22, so Sundrug's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +10.57% |
| 50-Day Moving Average | 4,555.14 |
| 200-Day Moving Average | 4,177.96 |
| Relative Strength Index (RSI) | 52.85 |
| Average Volume (20 Days) | 268,570 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sundrug had revenue of JPY 801.81 billion and earned 30.75 billion in profits. Earnings per share was 262.90.
| Revenue | 801.81B |
| Gross Profit | 204.09B |
| Operating Income | 44.50B |
| Pretax Income | 43.57B |
| Net Income | 30.75B |
| EBITDA | 61.78B |
| EBIT | 44.50B |
| Earnings Per Share (EPS) | 262.90 |
Balance Sheet
The company has 64.96 billion in cash and 38.67 billion in debt, giving a net cash position of 26.29 billion or 224.76 per share.
| Cash & Cash Equivalents | 64.96B |
| Total Debt | 38.67B |
| Net Cash | 26.29B |
| Net Cash Per Share | 224.76 |
| Equity (Book Value) | 269.71B |
| Book Value Per Share | 2,305.89 |
| Working Capital | 88.27B |
Cash Flow
In the last 12 months, operating cash flow was 41.16 billion and capital expenditures -33.45 billion, giving a free cash flow of 7.71 billion.
| Operating Cash Flow | 41.16B |
| Capital Expenditures | -33.45B |
| Free Cash Flow | 7.71B |
| FCF Per Share | 65.94 |
Margins
Gross margin is 25.45%, with operating and profit margins of 5.55% and 3.84%.
| Gross Margin | 25.45% |
| Operating Margin | 5.55% |
| Pretax Margin | 5.43% |
| Profit Margin | 3.84% |
| EBITDA Margin | 7.70% |
| EBIT Margin | 5.55% |
| FCF Margin | 0.96% |
Dividends & Yields
This stock pays an annual dividend of 131.00, which amounts to a dividend yield of 2.98%.
| Dividend Per Share | 131.00 |
| Dividend Yield | 2.98% |
| Dividend Growth (YoY) | 14.04% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 46.39% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 2.96% |
| Earnings Yield | 5.94% |
| FCF Yield | 1.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 29, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Sundrug has an Altman Z-Score of 4.85 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.85 |
| Piotroski F-Score | 6 |